A licence for breast cancer screening?

Abstract

It is unrealistic to expect that the best results which have been reported from some research programmes will be equalled after the introduction of a nationwide breast screening service in Britain. Stringent methods of quality control will be needed or potential benefits will not be realised. Despite the disadvantages an effective method of accreditation may be the only way to contain the cost to both healthy women and the National Health Service.